Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02094573
Title A Phase 2, Multicenter, Randomized Study of AP26113
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Ariad Pharmaceuticals
Indications

lung non-small cell carcinoma

Therapies

Brigatinib

Age Groups: adult
Covered Countries

Additional content available in CKB BOOST